Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, double-blind, placebo-controlled study evaluating endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

Trial Profile

Randomized, double-blind, placebo-controlled study evaluating endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Conjugated estrogens/medroxyprogesterone (Primary) ; Conjugated estrogens
  • Indications Endometrial hyperplasia; Menopausal syndrome
  • Focus Adverse reactions
  • Acronyms Woman's HOPE
  • Most Recent Events

    • 20 Mar 2018 Results comparing REPLENISH and Woman's HOPE trials in terms of endometrial protection and uterine bleeding profile presented at The 100th Annual Meeting of the Endocrine Society
    • 01 Jul 2001 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top